HIGHLIGHTS
- who: Ji Su Hwang and colleagues from the Department of Molecular Science and Technology, Ajou University, World Cup-ro, Suwon, Korea have published the research work: Development of Anticancer Peptides Using Artificial Intelligence and Combinational Therapy for Cancer Therapeutics, in the Journal: Pharmaceutics 2022, 14, 997. of /2022/
- future: In this review the authors mainly focus on the cutting-edge AI for ACP prediction and cover the mechanism of ACPs in cancer in the following three sections (i) development of therapeutic ACPs (ii) application of ML and DL for ACP development and_(iii) future approaches . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.